Pluri Inc. (PLUR)
PLUR trades on Nasdaq in Health Care, Biotechnology: Biological Products (No Diagnostic Substances). Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$0.9400
-3.08% on the day
Market cap
$11.9M
Nano cap
Revenue · 2025
$1.3M
+309.8% on 2024
Net income · 2025
-$22.6M
-1690.3% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | PLUR on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) |
| Country | Israel |
| IPO year | Not reported by the screener |
| SEC CIK | 0001158780 |
| SEC industry code | Biological Products, (No Diagnostic Substances) |
| Incorporated in | NV |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $1.3M |
| Net income | -$22.6M |
| Operating income | -$22.2M |
| Net margin | -1690.3% |
| Operating margin | -1659.9% |
| Revenue growth | +309.8% |
| Cash | $4.7M |
| Total assets | $30.6M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 8.9× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document REGISTRATION STATEMENT | S-1 | 2026-10-06 |
| Latest annual report ANNUAL REPORT | 10-K | 2026-09-10 |
| Latest quarterly / interim QUARTERLY REPORT | 10-Q | 2026-05-14 |
| Latest current report CURRENT REPORT | 8-K | 2026-08-28 |
| Latest proxy DEFINITIVE ADDITIONAL MATERIALS | DEFA14A | 2026-04-23 |
Source: SEC EDGAR submissions feed, 948 recent filings. All filings on EDGAR.
Peers in Biotechnology: Biological Products (No Diagnostic Substances)
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| PASG | Passage Bio Inc. | $3.64 | -20.00% | $11.7M |
| INAB | IN8bio Inc. | $1.18 | -4.07% | $11.6M |
| INTS | Intensity Therapeutics Inc. | $3.55 | +7.25% | $11.6M |
| ESLA | Estrella Immunopharma Inc. | $0.3140 | -4.44% | $13.7M |
| TCRX | TScan Therapeutics Inc. | $0.2167 | -8.91% | $13.8M |
| BCDA | BioCardia Inc. | $0.9903 | -2.91% | $15.0M |
| JSPR | Jasper Therapeutics Inc. | $0.4956 | -10.70% | $16.5M |
| DYAI | Dyadic International Inc. | $0.4253 | +1.00% | $17.0M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier